A new approach for stroke prevention in Russia

Cover Page


Cite item

Full Text

Abstract

The growing burden of stroke in Russia, along with the increasing cost of healthcare calls for new, more effective strategies for stroke prevention. These strategies should include increasing awareness of stroke symptoms, awareness of risk factors, and provision of easily available information on means of modifying risk factors. The Stroke Riskometer App is exactly such a tool, available in Russian, for adult individuals to calculate their risk of stroke over the next 5 and 10 years and identify their individual stroke risk factors and linking them to possible means of modifying these risk factors. The use of this App could reduce the risk of stroke for individuals in the Russian population and contribute to significant reduction in stroke burden in Russia

About the authors

V. L. Feigin

National Institute for Stroke and Applied Neurosciences at AUT University; University of Washington; Novosibirsk State Medical University

Author for correspondence.
Email: in-epid@yandex.ru
Новая Зеландия, Auckland, New Zealand; WA, USA; Novosibirsk, Russia

Yu. Ya. Varakin

Research Center of Neurology

Email: in-epid@yandex.ru
Новая Зеландия, Moscow

Mikhail A. Kravchenko

Research Center of Neurology

Email: in-epid@yandex.ru
Россия, Moscow

Mikhail A. Piradov

Research Center of Neurology

Email: in-epid@yandex.ru
ORCID iD: 0000-0002-6338-0392

D. Sci. (Med.), Professor, Full Member of the Russian Academy of Sciences, Director

Россия, Moscow

Marine M. Tanashyan

Research Center of Neurology

Email: in-epid@yandex.ru
ORCID iD: 0000-0002-5883-8119

D. Sci. (Med.), Prof., Corresponding member of RAS, Deputy Director for science, Head, 1st Neurological department

Россия, Moscow

Elena V. Gnedovskaya

Research Center of Neurology

Email: in-epid@yandex.ru
Россия, Moscow

L. V. Stakhovskaya

Research Institute of Cerebrovascular Pathology
and Stroke

Email: in-epid@yandex.ru
Россия, Moscow

N. A. Shamalov

N.I. Pirogov Russian National Research Medical University

Email: in-epid@yandex.ru
Россия, Moscow

R. Krishnamurthi

National Institute for Stroke and Applied Neurosciences at AUT University

Email: in-epid@yandex.ru
Новая Зеландия, Auckland

R. Bhattacharjee

National Institute for Stroke and Applied Neurosciences at AUT University

Email: in-epid@yandex.ru
Новая Зеландия, Auckland

P. Parmar

National Institute for Stroke and Applied Neurosciences at AUT University

Email: in-epid@yandex.ru
Новая Зеландия, Auckland

T. Hussein

National Institute for Stroke and Applied Neurosciences at AUT University

Email: in-epid@yandex.ru
Новая Зеландия, Auckland

S. Barker-Collo

National Institute for Stroke and Applied Neurosciences at AUT University

Email: in-epid@yandex.ru
Новая Зеландия, Auckland

References

  1. Ощепкова Е.В. О федеральной целевой программе «Профилактика и лечение АГ в Российской Федерации». Профилактика заболеваний и укрепление здоровья 2002; 1: 3–7.
  2. Стаховская Л.В., Клочихина О.А., Богатырева М.Д., Коваленко В.В. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009-2010). Журн.неврол. и психиатрии им. С.С. Корсакова 2013; 113 (5): 4–10.
  3. Суслина З.А., Варакин Ю.Я. Клиническое руководство по ранней диагностике, лечению и профилактике сосудистых заболеваний головного мозга. М.: МЕД пресс-информ, 2015.
  4. Brindle P., Emberson J., Lampe F. et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327 (7426): 1267.
  5. Cox J.L., Carr B., Vallis T.M. et al. A novel approach to cardiovascular health by optimizing risk management (ANCHOR): a primary prevention initiative examining the impact of health risk factor assessment and management on cardiac wellness. Can J Cardiol 2011; 27 (6): 809–817.
  6. D’Agostino R.B., Wolf P.A., Belanger A.J.et al. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994; 25 (1): 40–43.
  7. Ebrahim S., Taylor F., Ward K. et al. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011; 1: CD001561.
  8. Feigin V.L., Forouzanfar M.H., Krishnamurthi R. et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383 (9913): 245–254.
  9. Goldstein L.B., Bushnell C.D., Adams R.J. et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42(2): 517–584.
  10. Hippisley-Cox J., Coupland C., Brindle P. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. BMJ 2013; 346: 2573.
  11. Naghavi M., Wang H., Lozano R. et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385 (9963): 117–171.
  12. O’Donnell M.J., Xavier D., Liu L. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376 (9735): 112–123.
  13. Parmar P., Krishnamurthi R., Ikram M.A. et al. The Stroke Riskometer(TM) App: Validation of a data collection tool and stroke risk predictor. International journal of stroke : official journal of the International Stroke Society 2015; 10 (2): 231–244.
  14. Simons L.A., Simons J., McManus P. et al. Discontinuation rates for use of statins are high. BMJ 2000; 321 (7268): 1084.
  15. Vos T., Barber R.M., Bell B. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386 (9995): 743–800.
  16. Wartak S.A., Friderici J., Lotfi A. et al. Patients’ knowledge of risk and protective factors for cardiovascular disease. Am J Cardiol. 2011; 107 (10): 1480–1488.
  17. eMarketer Smartphone Users Worldwide Will Total 1.75 Billion in 2014: Mobile users pick up smartphones as they become more affordable, 3G and 4G networks advance 2014 [cited 2014 12 Dec]; Available from: http://www.emarketer.com/Article/Smartphone-Users-Worldwide-Will-Total-175-Billion-2014/1010536.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Feigin V.L., Varakin Y.Y., Kravchenko M.A., Piradov M.A., Tanashayan M.M., Gnedovskaya E.V., Stakhovskaya L.V., Shamalov N.A., Krishnamurthi R.-., Bhattacharjee R.-., Parmar P.-., Hussein T.-., Barker-Collo S.-.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies